NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
Back to search
Official data from USPTO
THERAPEUTICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THERAPEUTICA
ST13
US500000090237988Class
35
Filing
90237988
Registration
7803677
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
05/20/2025
Trademark type
Word
Nice classes
35
Filing date
10/06/2020
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/02/2020
First use in commerce
06/14/2024
Drawing code
4
Owner type
16
Owner location
Fort Lauderdale, FL
Examiner
SMITH, TARYN E
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Therapeutica Pharma Services LLC
Representatives
Michael Whittaker ACUITY LAW GROUP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business administration consultancy; Business management consultancy services
Publications
History of USPTO decisions and trademark events.
44 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/25/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/25/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/25/2025
ALIE
ASSIGNED TO LIE
04/25/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2025
GNRT
NON-FINAL ACTION E-MAILED
01/07/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/07/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/21/2024
IUAF
USE AMENDMENT FILED
06/14/2024
EISU
TEAS STATEMENT OF USE RECEIVED
06/14/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/13/2024
EX5G
SOU EXTENSION 5 GRANTED
01/12/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/09/2024
EXT5
SOU EXTENSION 5 FILED
12/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/17/2023
EX4G
SOU EXTENSION 4 GRANTED
06/15/2023
EXT4
SOU EXTENSION 4 FILED
06/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/15/2023
DOCK
ASSIGNED TO EXAMINER
01/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2022
EX3G
SOU EXTENSION 3 GRANTED
12/15/2022
EXT3
SOU EXTENSION 3 FILED
12/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/16/2022
EX2G
SOU EXTENSION 2 GRANTED
06/14/2022
EXT2
SOU EXTENSION 2 FILED
06/14/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/14/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2021
EX1G
SOU EXTENSION 1 GRANTED
12/15/2021
EXT1
SOU EXTENSION 1 FILED
12/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2021
DOCK
ASSIGNED TO EXAMINER
03/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/20/2020
NWAP
NEW APPLICATION ENTERED
10/09/2020
Continuous trademark protection
Get notified about every new filing that threatens THERAPEUTICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.